Key facts
- This page summarizes Philip D. Gregory's Form 4 filing for 2seventy bio, Inc. (TSVT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jan 2024, 16:09.
Philip D. Gregory - 05 Jan 2024 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- TSVT
- Reported as of
- 05 Jan 2024
- Net transaction value
- -$2,984
- SEC form
- 4
- Accepted by SEC
- 09 Jan 2024, 16:09:29 UTC
- Prior SEC filing
- 05 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Teresa Jurgensen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Philip D. Gregory filed Form 4 for 2seventy bio, Inc. (TSVT) on 09 Jan 2024.
Change
- Previous filing in this sequence was filed on 05 Jan 2024.
- Current net transaction value: -$2,984.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TSVT
transaction
Common Stock
Sale
- Transaction value
- $2,984
- Shares
- -795
- Change %
- -0.34%
- Price
- $3.75
- Shares after
- 230,842
- Date
- 05 Jan 2024
- Ownership
- Direct
- Footnotes
- F1, F2
TSVT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +79,438
- Change %
- +34%
- Price
- $0.000000
- Shares after
- 310,280
- Date
- 08 Jan 2024
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TSVT
transaction
Derivative
Stock Option (Right to buy)
Award
- Transaction value
- $0
- Shares
- +158,875
- Change %
- Price
- $0.000000
- Shares after
- 158,875
- Date
- 08 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 158,875
- Exercise price
- $3.97
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units ("RSUs").
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.675 to $3.83, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
RSU awards vest over a four-year period at the rate of 25% on 01/02/2025, 25% on 01/02/2026, 25% on 01/02/2027, and 25% on 01/02/2028.
Footnote F4
This stock option vests over a four-year period at the rate of 25% on 01/02/2025, and then in 36 equal monthly installments thereafter.